MCAT Biological and Biochemical Foundations of Living Systems Quiz: 2c Cell Cycle Regulation

What this quiz covers

This quiz focuses on 2c Cell Cycle Regulation, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. M phase, due to defective kinetochore-microtubule attachment
2. S phase, due to failure of replication fork formation
3. G2 phase, due to reduced activation of cyclin B–CDK1
4. G0, due to continued passage through the G1 restriction point (correct answer)

Explanation: This question explores quiescence (G0) regulation and the G1 restriction point's response to nutrient status. The principle is that nutrient deprivation induces G0 entry before the restriction point, but active G1 CDK allows passage into S phase, bypassing quiescence. Population 2 with constitutive G1 cyclin-CDK fails to enter quiescence under deprivation, unlike controls. The correct answer, bypassing G0 due to continued restriction point passage, fits as unchecked CDK activity prevents G0 arrest. A distractor like S-phase bypass fails by assuming replication defects instead of G1 deregulation, misconstruing nutrient sensing. For such questions, differentiate G0 from cycling phases by cyclin levels. Reason by predicting if mutations sustain progression signals, leading to bypassed arrest states.

Question 2

1. G2 to M transition, because replication stress signaling helps delay mitotic entry until DNA synthesis is complete (correct answer)
2. M to G1 transition, because ATR is required to activate cytokinesis
3. G1 to S transition, because ATR is the primary driver of Rb phosphorylation
4. S to G1 transition, because ATR directly degrades cyclin D to reset the cell cycle

Explanation: This question assesses knowledge of ATR's role in the intra-S checkpoint and its connection to preventing premature mitotic entry during replication stress. ATR kinase responds to stalled replication forks by activating checkpoint signaling that both stabilizes forks and prevents cells from entering mitosis with incompletely replicated DNA. When ATR is inhibited during hydroxyurea-induced replication stress, cells lose this protective checkpoint and proceed to mitosis with under-replicated DNA, causing chromosomal breaks in daughter cells. The correct answer A identifies the G2/M transition as most directly compromised, as ATR signaling delays mitotic entry until DNA synthesis completes. Option B incorrectly links ATR to cytokinesis; option C wrongly makes ATR primary for Rb phosphorylation; option D describes an impossible S to G1 transition. When analyzing replication stress responses, remember ATR monitors replication fork integrity and coordinates both fork stabilization and cell cycle checkpoints to prevent mitotic catastrophe.

Question 3

1. Increased degradation of cyclin B, preventing entry into mitosis
2. Failure to arrest at the G1/S checkpoint due to reduced p53-dependent induction of CDK inhibitors (correct answer)
3. Enhanced activation of separase, leading to premature sister chromatid separation in metaphase
4. Constitutive activation of the spindle assembly checkpoint, prolonging anaphase onset

Explanation: This question tests understanding of DNA damage checkpoints in cell cycle regulation. The principle assessed is how ATM kinase activates p53 to induce CDK inhibitors like p21, arresting cells at G1/S after DNA damage to allow repair. In this scenario, ionizing radiation causes double-strand breaks, normally leading to G1 accumulation via ATM-p53-p21 pathway, but ATM inhibition prevents this arrest. Choice B is consistent because inhibiting ATM reduces p53 activation and CDK inhibitor induction, allowing progression into S phase with replication stress. Choice A fails as it describes mitotic regulation unrelated to G1/S checkpoint or ATM's primary role, a common misconception linking all checkpoints to cyclin degradation. To verify similar questions, recall that ATM/ATR kinases primarily act on G1/S and G2/M checkpoints via p53 and Chk1/2. A useful strategy is to map the damage type to the sensor kinase and downstream effectors for checkpoint specificity.

Question 4

1. Inhibition of CDK4/6 activity, preventing cyclin D-dependent Rb phosphorylation and delaying G1/S progression (correct answer)
2. Activation of CDK1 activity, accelerating the G2/M transition
3. Direct activation of APC/C, promoting rapid cyclin B degradation in early G1
4. Enhanced telomerase activity, extending replicative lifespan and increasing S-phase entry

Explanation: This question evaluates understanding of p16INK4a as a CDK inhibitor that regulates the G1/S transition by preventing Rb phosphorylation. p16INK4a specifically inhibits CDK4 and CDK6, preventing their association with cyclin D and thus blocking Rb phosphorylation, which keeps Rb bound to E2F and prevents S-phase gene expression. Overexpression of p16INK4a therefore causes G1 arrest with hypophosphorylated Rb and reduced DNA synthesis genes, as observed in the experiment. The correct answer A accurately describes this mechanism - inhibition of CDK4/6 preventing cyclin D-dependent Rb phosphorylation. Option B incorrectly suggests CDK1 activation; option C wrongly involves APC/C in G1; option D incorrectly links p16 to telomerase. When analyzing CDK inhibitor questions, match the specific inhibitor to its target: p16INK4a inhibits CDK4/6, p21 inhibits multiple CDKs, and p27 primarily targets CDK2.

Question 5

1. G0, because proteasome inhibition directly prevents quiescence
2. S phase, because proteasome inhibition blocks DNA polymerase activity
3. M phase, because timely destruction of mitotic regulators is required for anaphase and mitotic exit (correct answer)
4. G1 phase, because proteasome inhibition immediately eliminates cyclin D expression

Explanation: This question evaluates understanding of proteasome-dependent protein degradation in cell cycle regulation, particularly during mitosis. The proteasome degrades ubiquitinated proteins including cyclins and other regulators whose timely destruction is essential for cell cycle progression, especially during mitotic exit when cyclin B and securin must be degraded. Proteasome inhibition causes accumulation of these proteins and prevents progression through late mitosis, as cells cannot degrade cyclin B to exit mitosis or securin to initiate anaphase. The correct answer C identifies M phase as most affected because mitotic progression requires rapid, precisely timed protein degradation. Option A incorrectly suggests proteasomes prevent quiescence; option B wrongly links proteasomes to DNA polymerase; option D incorrectly states proteasome inhibition eliminates cyclin D when it actually causes accumulation. When analyzing proteasome function in cell cycle, focus on phases requiring rapid protein turnover - particularly the metaphase-to-anaphase transition and mitotic exit where APC/C-mediated ubiquitination targets proteins for proteasomal degradation.

Question 6

1. Enhanced G1 restriction point control due to increased cyclin D degradation
2. Delayed mitotic entry due to strengthened inhibitory phosphorylation of CDK1
3. Checkpoint bypass at G2/M, promoting mitotic entry before completion of DNA repair (correct answer)
4. Reduced chromosome condensation due to inhibition of condensin activation during prophase

Explanation: This question tests understanding of how Cdc25 phosphatase regulates CDK1 activation and the consequences of overriding the G2/M checkpoint. Cdc25 removes inhibitory phosphates from CDK1, promoting mitotic entry; normally, DNA damage checkpoints prevent Cdc25 activation to delay mitosis until repair is complete. By agonizing Cdc25 after UV damage, the experiment forces premature CDK1 activation and mitotic entry before DNA repair, leading to micronuclei formation from damaged chromosomes. The correct answer C describes this checkpoint bypass at G2/M, promoting mitotic entry before DNA repair completion. Option A incorrectly focuses on G1 and cyclin D; option B suggests delayed entry when the agonist causes earlier entry; option D wrongly focuses on chromosome condensation rather than checkpoint override. For checkpoint override questions, recognize that forcing activation of mitotic promoters (like Cdc25) or inhibiting checkpoint kinases (like ATM/ATR) allows damaged cells to enter mitosis prematurely.

Question 7

1. G1 phase, because loss of Rb function reduces control of the G1/S transition under growth-limiting conditions (correct answer)
2. S phase, because Rb directly catalyzes nucleotide incorporation during DNA replication
3. G2 phase, because Rb is required to activate CDK1 for mitotic entry
4. M phase, because Rb is the primary component of the spindle assembly checkpoint

Explanation: This question assesses understanding of Rb's role in contact inhibition and G1 arrest in response to high cell density. Normal cells exhibit contact inhibition, accumulating in G1 when crowded, which requires functional Rb to maintain G1 arrest by sequestering E2F transcription factors. The viral oncoprotein inactivates Rb, preventing this density-dependent G1 arrest and allowing continued cycling despite high density, similar to transformed cells that have lost contact inhibition. The correct answer A identifies G1 phase as most affected, as Rb inactivation reduces control of the G1/S transition under growth-limiting conditions like high density. Option B incorrectly assigns Rb a direct replication role; option C wrongly links Rb to CDK1 activation; option D incorrectly makes Rb a SAC component. When analyzing contact inhibition or growth arrest questions, remember that Rb mediates G1 arrest in response to various anti-proliferative signals including contact inhibition, growth factor withdrawal, and differentiation cues.

Question 8

1. Reduced activation of APC/C, leading to enhanced securin stabilization and tighter chromatid cohesion
2. Increased p53-dependent G1 arrest, preventing cells from entering mitosis
3. Premature APC/C activity, allowing anaphase onset despite improper kinetochore attachment (correct answer)
4. Enhanced DNA replication licensing, causing rereplication during S phase

Explanation: This question tests understanding of the spindle assembly checkpoint (SAC) and how its disruption leads to premature anaphase onset with chromosome missegregation. The SAC, with MAD2 as a key component, normally prevents APC/C activation until all kinetochores are properly attached to spindle microtubules, ensuring accurate chromosome segregation. When MAD2 is knocked down, the checkpoint is weakened, allowing premature APC/C activation and anaphase onset even when kinetochores are improperly attached due to the microtubule-destabilizing drug. The correct answer C describes this outcome - premature APC/C activity allowing anaphase despite improper attachments. Option A incorrectly suggests reduced APC/C activation; option B wrongly invokes p53 and G1 arrest; option D incorrectly focuses on DNA replication rather than mitosis. For SAC questions, remember that checkpoint proteins like MAD2 inhibit APC/C until proper spindle attachments form, and checkpoint disruption causes premature anaphase with increased aneuploidy risk.

Question 9

1. Early G1 phase prior to passing the restriction point (correct answer)
2. S phase due to reduced DNA polymerase processivity
3. M phase due to impaired spindle microtubule formation
4. G2 phase due to impaired activation of separase

Explanation: This question tests cyclin D's role in G1 progression. Principle: cyclin D-CDK4/6 phosphorylates Rb, releasing E2F for S-gene transcription; knockdown reduces this, lengthening early G1. Knockdown leads to low Rb phosphorylation and replication gene transcription. Choice A is consistent as reduced cyclin D extends G1 before restriction point. Choice B fails, implying S-phase defect, but transcription block is G1-specific, misconstruing cyclin D as replication factor. For similar knockdowns, monitor Rb status and gene expression. Strategy: differentiate early G1 (mitogen-sensitive) from late (committed).

Question 10

1. G2/M DNA damage checkpoint that restrains CDK1 activation until repair is complete (correct answer)
2. Spindle assembly checkpoint that monitors kinetochore attachment
3. Restriction point in late G1 that senses extracellular mitogens
4. Cytokinesis checkpoint that ensures abscission occurs after chromosome segregation

Explanation: This question assesses DNA damage checkpoints involving ATR-Chk1. The principle is ATR activates Chk1 after UV damage, inhibiting Cdc25 to phosphorylate CDK1 and enforce G2/M arrest for repair. UV exposure activates ATR-Chk1; inhibiting Chk1 allows mitotic entry with lesions, causing breaks. Choice A is consistent as Chk1 inhibition compromises G2/M checkpoint, permitting mitosis with damage. Choice B is wrong, focusing on spindle checkpoint irrelevant to DNA damage, a misconception blending checkpoints. For similar scenarios, identify damage type (UV for ATR) and effector (Chk1 for G2). Strategy: trace kinase cascade to CDK target and phase affected.

Question 11

1. Reduced inhibition of CDK4/6 promotes Rb phosphorylation and E2F release at the G1 restriction point (correct answer)
2. Increased inhibition of CDK1 prevents activation of cyclin B and delays mitosis
3. Enhanced APC/C activity degrades securin and triggers anaphase prematurely
4. Activation of ATR induces p53 degradation and accelerates DNA repair

Explanation: This question examines CDK inhibitors like p16 in G1 progression. The principle is p16 inhibits CDK4/6, preventing Rb phosphorylation and E2F release; loss allows unchecked CDK activity and early S-gene expression. Mutant keratinocytes show increased Rb phosphorylation and premature S-phase genes post-mitogen. Choice A is consistent as reduced p16 inhibition promotes CDK4/6, Rb phosphorylation, and G1/S progression. Choice B is incorrect, describing CDK1 inhibition which delays mitosis, not G1 effects, a common mix-up of CDK types. For similar questions, recall inhibitor-CDK specificity: p16 for G1 CDKs. Verify by linking mutation to phosphorylation changes and gene expression timing.

Question 12

1. Increased entry into mitosis despite unrepaired DNA double-strand breaks due to reduced G2/M checkpoint enforcement (correct answer)
2. Failure to initiate DNA replication due to premature activation of the G1/S restriction point
3. Enhanced sister chromatid cohesion due to hyperactivation of the spindle assembly checkpoint
4. Permanent arrest in metaphase due to loss of anaphase-promoting complex/cyclosome (APC/C) activity

Explanation: This question tests understanding of the ATM-dependent G2/M checkpoint that prevents cells with DNA damage from entering mitosis. ATM kinase is activated by DNA double-strand breaks and phosphorylates checkpoint proteins that halt cell cycle progression at G2/M, allowing time for DNA repair before mitosis. In this experiment, ionizing radiation causes DNA damage, but ATM inhibition prevents checkpoint activation, so cells with unrepaired damage proceed through the G2/M transition into mitosis rather than accumulating with 4N DNA content in G2. The correct answer A accurately describes this outcome - cells enter mitosis despite unrepaired DNA breaks due to reduced checkpoint enforcement. Option B is incorrect because ATM functions at G2/M, not G1/S; option C incorrectly suggests enhanced cohesion when checkpoint failure would reduce it; and option D wrongly predicts metaphase arrest when ATM inhibition actually allows progression past checkpoints. When analyzing DNA damage checkpoint questions, focus on which checkpoint (G1/S vs G2/M) is relevant based on the kinase involved (ATR/CHK1 for replication stress, ATM/CHK2 for double-strand breaks) and predict whether inhibition will cause checkpoint bypass or arrest.

Question 13

1. Inhibited DNA replication forces immediate cytokinesis to reduce genome content
2. DNA polymerase inhibition directly activates APC/C, causing premature cyclin B degradation
3. Blocked DNA synthesis increases Rb phosphorylation, accelerating the restriction point
4. Incomplete DNA replication activates checkpoints that prevent full activation of cyclin B–CDK1 (correct answer)

Explanation: This question examines intra-S checkpoint effects on mitotic entry. Principle: Incomplete replication activates checkpoints inhibiting CDK1, preventing mitosis until resolution; polymerase block sustains cyclin A, delaying entry. Treated cells show high cyclin A and no mitosis. Choice D is consistent as checkpoints block cyclin B-CDK1 activation. Choice B fails, suggesting APC/C activation causes degradation, but high cyclin indicates arrest, misconstruing as exit promoter. For verification, note cyclin persistence and phase markers. Strategy: differentiate replication blocks from post-S events by cyclin types.

Question 14

1. Failure to initiate DNA replication due to loss of cyclin E
2. Inability to trigger anaphase due to reduced ubiquitination of securin and cyclin B (correct answer)
3. Accelerated cytokinesis due to increased actin polymerization
4. G1 arrest due to increased p16 inhibition of CDK4/6

Explanation: This question examines APC/C's role in anaphase onset. Principle: Cdc20 activates APC/C to ubiquitinate securin and cyclin B, triggering separase and mitotic progression; mutant prevents this, causing metaphase arrest with high securin. Mutant cells show persistent metaphase and securin levels. Choice B is consistent as failed ubiquitination blocks anaphase. Choice A fails, implying replication defect, but arrest is mitotic, misconstruing APC/C as S-phase regulator. For verification, check substrate levels like securin. Strategy: link APC/C activators to targets and mitotic subphases.

Question 15

1. G1 to S transition due to persistent inhibition of CDK4/6
2. S to G2 transition due to impaired origin licensing
3. Metaphase to anaphase transition due to sustained CDK1 activity (correct answer)
4. Cytokinesis to G1 transition due to loss of telomerase activity

Explanation: This question evaluates knowledge of mitotic progression and the role of cyclin degradation in cell cycle regulation. The principle involved is that cyclin B must be degraded by the APC/C to inactivate CDK1, allowing exit from metaphase and progression to anaphase. In the vignette, cells expressing nondegradable cyclin B form spindles but fail to separate chromosomes, indicating a block at the metaphase-anaphase transition. The correct answer, impaired metaphase to anaphase due to sustained CDK1 activity, aligns because persistent cyclin B maintains CDK1 activity, preventing separase activation and cohesin cleavage. A distractor like impaired G1/S transition fails as it ignores the mitotic context and cyclin B's specificity to M phase, a common error in confusing cyclin types. For similar problems, confirm the cyclin-CDK pair's phase specificity and degradation requirements. Always cross-check phenotypes like spindle formation with mitotic subphases to pinpoint the exact transition affected.

Question 16

1. Inhibition of cyclin B–CDK1 activity, delaying cytokinesis completion
2. Activation of separase, accelerating sister chromatid separation
3. Stimulation of APC/C, increasing cyclin A synthesis
4. Inhibition of cyclin E–CDK2 activity, delaying G1/S transition (correct answer)

Explanation: This question investigates CDK inhibitors' impact on cell cycle transitions. The principle is that p21 inhibits cyclin E-CDK2, blocking Rb phosphorylation and E2F release to delay G1/S transition. Overexpressing p21 causes delayed S-phase entry after synchronization, independent of p53. The correct answer, inhibition of cyclin E-CDK2 delaying G1/S, matches as p21 targets this complex to enforce arrest. A distractor like separase activation fails by linking p21 to mitosis, a misconception ignoring its G1/S preference. For related scenarios, connect inhibitors to specific CDK-cyclin pairs and phases. A useful check is to assess timing of delays relative to cycle stages for confirmation.

Question 17

1. Reduced E2F activity, decreasing transcription of DNA synthesis enzymes
2. Constitutive release of E2F, promoting transcription of S-phase genes (correct answer)
3. Enhanced p53 stabilization, increasing p21-mediated CDK inhibition
4. Increased spindle checkpoint signaling, prolonging metaphase arrest

Explanation: This question tests the role of Rb in regulating the G1/S transition via growth factor signals. The principle is that Rb binds and represses E2F; its phosphorylation by CDKs releases E2F to promote S-phase gene transcription, but Rb loss allows constitutive E2F activity. The tumor cells with RB1 mutation enter S phase under low growth factors, unlike controls. The correct answer, constitutive E2F release promoting S-phase genes, aligns as Rb absence removes repression, enabling unchecked progression. A distractor like reduced E2F activity fails by reversing Rb's inhibitory role, a common error in tumor suppressor functions. For related queries, recall Rb as a brake on E2F, lost in many cancers. Check phenotypes like factor-independent proliferation to confirm G1/S deregulation.

Question 18

1. CHK1-mediated inhibition of Cdc25, maintaining CDK1 in an inhibited state (correct answer)
2. CHK1-mediated activation of APC/C, promoting cyclin D degradation
3. CHK1-mediated activation of E2F, increasing transcription of S-phase genes
4. CHK1-mediated inhibition of separase, preventing cohesin loading in G1

Explanation: This question examines the DNA damage response at the G2/M checkpoint involving CHK1 signaling. The core principle is that DNA damage activates CHK1, which phosphorylates and inhibits Cdc25, maintaining CDK1 in an inactive phosphorylated state to delay mitosis. The experiment shows CHK1 activation post-damage reduces CDK1 activity and delays mitosis, with dominant-negative CHK1 diminishing this delay. The correct answer, CHK1-mediated inhibition of Cdc25 keeping CDK1 inhibited, is fitting as it directly explains the mechanism preventing premature mitosis. A distractor like CHK1 activating APC/C fails by incorrectly linking CHK1 to mitotic exit rather than entry control, misconstruing checkpoint targets. In similar questions, map kinase cascades to their effectors, like CHK1 to Cdc25 for G2/M. A transferable strategy is to compare wild-type and mutant responses to identify the disrupted pathway's function.

Question 19

1. G2 phase, with impaired activation of cyclin B–CDK1
2. S phase, with impaired separation of sister chromatids
3. G1 phase, with impaired progression past the restriction point (correct answer)
4. M phase, with impaired kinetochore attachment to microtubules

Explanation: This question assesses comprehension of the G1 restriction point and CDK4/6's role in cell cycle progression. The key principle is that CDK4/6 phosphorylates Rb, releasing E2F to transcribe genes needed for S-phase entry, marking passage through the restriction point. The scenario describes a CDK4/6 inhibitor reducing Rb phosphorylation and E2F targets, leading to impaired G1 progression in cancer cells. The correct answer, G1 phase with impaired restriction point progression, is consistent as blocking CDK4/6 prevents Rb inactivation, halting E2F-mediated transcription. A distractor like S-phase impairment with chromatid issues fails by misattributing CDK4/6 to replication rather than G1 regulation, overlooking phase-specific CDK functions. To approach similar questions, identify the CDK target's downstream effects, such as Rb-E2F for G1/S. Verify by noting that reduced E2F activity specifically delays S entry without affecting later phases like mitosis.

Question 20

1. Impaired intra-S-phase checkpoint, allowing replication to continue despite DNA damage (correct answer)
2. Enhanced G2/M checkpoint, preventing entry into mitosis after damage
3. Increased APC/C activity, accelerating metaphase-to-anaphase transition
4. Reduced Rb phosphorylation, strengthening the G1 restriction point

Explanation: This question assesses the intra-S checkpoint's role in replication stress response. The principle is that ATM detects replication-induced damage and signals to slow origin firing and fork progression, preventing further damage accumulation. Wild-type cells slow synthesis post-topoisomerase inhibitor, but ATM-deficient cells continue replication with damage buildup. The correct answer, impaired intra-S checkpoint allowing continued replication despite damage, is consistent as ATM loss disables this protective slowdown. A distractor like enhanced G2/M checkpoint fails by shifting focus to mitosis, ignoring S-phase specificity and ATM's role there. Approach similar problems by identifying the damage type and phase to match checkpoints. Verify by noting unchecked progression leads to amplified damage markers in mutants.